Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Giulia Marzolla"'
Autor:
Federica Di Nicolantonio, Ryan B. Corcoran, Salvatore Siena, Alberto Bardelli, Andrea Sartore-Bianchi, Jeffrey A. Engelman, Josep Tabernero, Jan H.M. Schellens, René Bernards, Margherita Gallicchio, Julieta Grasselli, Giulia Siravegna, Mauro Truini, Giorgio Corti, Michael Linnebacher, Carlotta Cancelliere, Michela Buscarino, Jason T. Godfrey, Valentina Boscaro, Giovanni Crisafulli, Alice Bartolini, Robin M.J.M. van Geel, Elena Elez, Giulia Marzolla, Genny Filiciotto, Andrea Cassingena, Sabrina Arena, Emanuele Valtorta, Ludovic Barault, Erin M. Sennott, Daniele Oddo
The file lists Supplementary Materials and Methods and relative References.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b498f8adc90bf218a6ea043154f15e
https://doi.org/10.1158/0008-5472.22413579
https://doi.org/10.1158/0008-5472.22413579
Autor:
Federica Di Nicolantonio, Ryan B. Corcoran, Salvatore Siena, Alberto Bardelli, Andrea Sartore-Bianchi, Jeffrey A. Engelman, Josep Tabernero, Jan H.M. Schellens, René Bernards, Margherita Gallicchio, Julieta Grasselli, Giulia Siravegna, Mauro Truini, Giorgio Corti, Michael Linnebacher, Carlotta Cancelliere, Michela Buscarino, Jason T. Godfrey, Valentina Boscaro, Giovanni Crisafulli, Alice Bartolini, Robin M.J.M. van Geel, Elena Elez, Giulia Marzolla, Genny Filiciotto, Andrea Cassingena, Sabrina Arena, Emanuele Valtorta, Ludovic Barault, Erin M. Sennott, Daniele Oddo
Although recent clinical trials of BRAF inhibitor combinations have demonstrated improved efficacy in BRAF-mutant colorectal cancer, emergence of acquired resistance limits clinical benefit. Here, we undertook a comprehensive effort to define mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd302bf0210c3bfc933df8f749f88ac8
https://doi.org/10.1158/0008-5472.c.6508761.v1
https://doi.org/10.1158/0008-5472.c.6508761.v1
Autor:
Federica Di Nicolantonio, Ryan B. Corcoran, Salvatore Siena, Alberto Bardelli, Andrea Sartore-Bianchi, Jeffrey A. Engelman, Josep Tabernero, Jan H.M. Schellens, René Bernards, Margherita Gallicchio, Julieta Grasselli, Giulia Siravegna, Mauro Truini, Giorgio Corti, Michael Linnebacher, Carlotta Cancelliere, Michela Buscarino, Jason T. Godfrey, Valentina Boscaro, Giovanni Crisafulli, Alice Bartolini, Robin M.J.M. van Geel, Elena Elez, Giulia Marzolla, Genny Filiciotto, Andrea Cassingena, Sabrina Arena, Emanuele Valtorta, Ludovic Barault, Erin M. Sennott, Daniele Oddo
Supplementary Tables S1-S3 - List of drug concentrations to generate resistant cell lines (S1); Drug concentrations applied in the screening depicted in Figure 6 (S2); Primers for gene amplification and sequencing (S3). Supplementary Figure S1. Syner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::830ffd5c23cf95e6083c2e506f487ecb
https://doi.org/10.1158/0008-5472.22413582
https://doi.org/10.1158/0008-5472.22413582
Autor:
Federica Di Nicolantonio, Ryan B. Corcoran, Salvatore Siena, Alberto Bardelli, Andrea Sartore-Bianchi, Jeffrey A. Engelman, Josep Tabernero, Jan H.M. Schellens, René Bernards, Margherita Gallicchio, Julieta Grasselli, Giulia Siravegna, Mauro Truini, Giorgio Corti, Michael Linnebacher, Carlotta Cancelliere, Michela Buscarino, Jason T. Godfrey, Valentina Boscaro, Giovanni Crisafulli, Alice Bartolini, Robin M.J.M. van Geel, Elena Elez, Giulia Marzolla, Genny Filiciotto, Andrea Cassingena, Sabrina Arena, Emanuele Valtorta, Ludovic Barault, Erin M. Sennott, Daniele Oddo
Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ae184372f1020068c41c3a360c8e56
https://doi.org/10.1158/0008-5472.22413585
https://doi.org/10.1158/0008-5472.22413585
Autor:
Andrea Sartore-Bianchi, Margherita Gallicchio, Erin M. Sennott, Alice Bartolini, Federica Di Nicolantonio, Julieta Grasselli, Valentina Boscaro, Alberto Bardelli, Jan H.M. Schellens, Giovanni Crisafulli, Salvatore Siena, Jason T. Godfrey, Andrea Cassingena, Jeffrey A. Engelman, Genny Filiciotto, Giorgio Corti, Giulia Siravegna, Mauro Truini, Josep Tabernero, Giulia Marzolla, Michael Linnebacher, Carlotta Cancelliere, Sabrina Arena, René Bernards, Emanuele Valtorta, Ludovic Barault, Daniele Oddo, Michela Buscarino, Ryan B. Corcoran, Elena Elez, Robin M.J.M. van Geel
Publikováno v:
Cancer Research
Cancer Research, 76(15), 4504-4515. American Association for Cancer Research Inc.
Cancer Research, 76(15), 4504-4515. American Association for Cancer Research Inc.
Although recent clinical trials of BRAF inhibitor combinations have demonstrated improved efficacy in BRAF-mutant colorectal cancer, emergence of acquired resistance limits clinical benefit. Here, we undertook a comprehensive effort to define mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b75892ae1f547d111434229a042c4a
https://cris.maastrichtuniversity.nl/en/publications/d6475322-dc21-4472-a221-427cede7b2e7
https://cris.maastrichtuniversity.nl/en/publications/d6475322-dc21-4472-a221-427cede7b2e7
